A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.
Then, we also classified the patients according to the presence of ILD events and analysed their characteristics. Results Tumour necrosis factor (TNF) inhibitors were administered to more patients ...
A previous retrospective study from the same team had established a link between early treatment and reduced likelihood of perianal fistulas. That research, however, was unable to confirm that ...
Methods Patients with RA (n=9139; 76% women; mean age 56 years) starting their first tumour necrosis factor (TNF) inhibitor between 2003 and 2011 were identified in the Swedish Biologics Register ...
You will be able to get a quick price and instant permission to reuse the content in many different ways. Request permissions It has been reported that tumour necrosis factor (TNF) inhibitors have ...
Beau-Sejour, 1211 Geneva 14. Switzerland; axel.finckh{at}hcuge.ch or cem.gabay{at}hcuge.ch Background: Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (TNF) agents ...